Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
Clinical trial NCT05239741 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05239741
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-02
- Primary completion
- 2028-09-19
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.